Klaus Hackner

7PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Palliative carePredictive and prognostic markersLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Pre- or Perioperative Immunotherapy Combined with Chemotherapy Versus Chemotherapy Alone in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review.

|Oct 27, 2022
A Retrospective, Single-Center Analysis of Specialized Palliative Care Services for Patients with Advanced Small-Cell Lung Cancer.

Claudia Wachter, Klaus Hackner, Iris Groissenberger

|Apr 23, 2022
Lymph but Not Blood Vessel Invasion Is Independent Prognostic in Lung Cancer Patients Treated by VATS-Lobectomy and Might Represent a Future Upstaging Factor for Early Stages.

Melanie Biesinger, Nele Eicken, Alexander Varga

|Mar 03, 2022
Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination protocol.

Klaus Hackner, Antonia Stadler, Felix Schragel

|Mar 01, 2021
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.

Klaus Hackner, Anna Buder, Maximilian J Hochmair

|Jun 18, 2019
Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.

Klaus Hackner, Peter Errhalt, Sabin Handzhiev

Pageof 2

Frequent Collaborators

2 joint publications

Bahil Ghanim

1 joint publications

Peter Errhalt

1 joint publications

Franziska Jutz

1 joint publications

Nguyen-Son Le